| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.09B | -5.7% |
| Gross profit | ¥0.01B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.00B | — |
| Gross margin | 14.1% | Net margin 4.4% |
| Revenue Q/Q | +117.1% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.08B | 85.9% |
| R&D | ¥0.01B | 7.0% |
| SG&A | ¥0.01B | 16.5% |
| Tax & other | ¥0.00B | 2.9% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
美畅股份 ・ 蓝盾光电 ・ 卡倍亿 ・ 南大环境 ・ 大宏立 ・ 圣元环保 ・ 杰美特 ・ 康泰医学 ・ 欧陆通 ・ 回盛生物 ・ 天阳科技 ・ 海晨股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies